1/57
Comprehensive vocabulary flashcards covering glycogen metabolism, glycogen storage diseases, the pyruvate dehydrogenase complex, the citric acid cycle, electron transport chain complexes, ATP synthase, and mitochondrial shuttle mechanisms.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Glycogen
A polymeric storage form of glucose located primarily in muscle, where its breakdown delivers glucose for contraction, and in the liver, where it serves as a reservoir for maintaining blood glucose homeostasis.
β-Granules
Cytosolic, electron-dense particles varying in size, structure, and subcellular location that cluster in the liver to form α-granules.
α-Granules
Protein-rich liver granules composed of 20 to 40 clustered β-granules that release glucose more slowly than individual β-granules, associate with smooth endoplasmic reticulum (SER) tubules, and disappear after a 24-hour fast.

Glycogen Particle Structure
A spherical particle nucleated by a central glycogenin dimer acting as a primer, from which chains of 12 to 14 glucose residues extend in 12 tiers; inner chains have two (α1→6) branches each, while outer tier chains are unbranched.
Glycogen Phosphorylase
An enzyme that catalyzes phosphorolytic cleavage at nonreducing ends of glycogen using inorganic phosphate (Pi) and pyridoxal phosphate as a cofactor, releasing glucose 1-phosphate (G1P) until reaching four residues away from an (α1→6) branch point.
Debranching Enzyme (Transferase Activity)
The catalytic activity of glycogen debranching enzyme that shifts a block of three glucose residues from a branch point to a nearby nonreducing end, leaving a single glucose residue attached via an (α1→6) bond.
Debranching Enzyme ((α1→6) Glucosidase Activity)
The hydrolytic activity of glycogen debranching enzyme that cleaves the single remaining (α1→6)-linked glucose residue at a branch point, releasing it as a free glucose molecule rather than G1P.
Phosphoglucomutase
An enzyme that catalyzes the reversible isomerization of glucose 1-phosphate (G1P) and glucose 6-phosphate (G6P) through a phosphorylated serine residue intermediate that creates a glucose 1,6-bisphosphate intermediate.

Glucose 6-Phosphatase System
An ER lumen-sequestered enzyme complex present only in liver and kidney cells that dephosphorylates G6P transported by T1 into free glucose, which exits through T2 and GLUT2 into the blood to support systemic blood glucose homeostasis.
UDP-Glucose Pyrophosphorylase
An enzyme that catalyzes the condensation of glucose 1-phosphate (G1P) and uridine triphosphate (UTP) to produce UDP-glucose and inorganic pyrophosphate (PPi), a reaction driven forward by pyrophosphate hydrolysis.
Glycogenin
A self-glucosylating protein dimer that primes glycogen synthesis by attaching a glucose residue from UDP-glucose to its Tyr194 residue and adding seven more glucose units to build an eight-residue chain.
Glycogen Synthase
The primary chain-elongation enzyme in glycogenesis that transfers glucosyl residues from UDP-glucose to the nonreducing end of an existing glycogen chain of at least eight residues, forming (α1→4) glycosidic linkages.
Glycogen-Branching Enzyme
An enzyme that creates (α1→6) branches during glycogen synthesis by transferring a segment of seven residues from the nonreducing end to an interior position at least four residues away from the glycogenin core and eleven residues away from an existing branch point.
Allosteric Regulation of Glycogen Phosphorylase
Regulation of glycogen breakdown wherein glycogen phosphorylase is activated by high levels of AMP and inhibited by high levels of ATP and glucose 6-phosphate (G6P).
Allosteric Regulation of Glycogen Synthase
Regulation of glycogen synthesis wherein glycogen synthase is allosterically activated by high levels of glucose 6-phosphate (G6P) and inhibited by high concentrations of AMP, which signals cellular energy depletion.
Von Gierke Disease (Type Ia)
A glycogen storage disease caused by a genetic deficiency in glucose 6-phosphatase in the liver, leading to liver enlargement (hepatomegaly) and kidney failure.
Pompe Disease (Type II)
A glycogen storage disease caused by a deficiency in lysosomal glucosidase affecting skeletal and cardiac muscle, resulting in infantile early death, juvenile myopathy, or adult muscular dystrophy-like symptoms.
Cori Disease / Forbes Disease (Type IIIa)
A glycogen storage disease caused by a deficiency of the debranching enzyme in the liver, skeletal muscle, and cardiac muscle, characterized by an enlarged liver in infants and myopathy.
Andersen Disease (Type IV)
A glycogen storage disease caused by a genetic defect in branching enzyme affecting the liver and skeletal muscle, marked by an enlarged liver and spleen and myoglobin in the urine.
McArdle Disease (Type V)
A glycogen storage disease caused by a deficiency in muscle glycogen phosphorylase, leading to exercise-induced painful muscle cramps and myoglobinuria.
Hers Disease (Type VI)
A glycogen storage disease caused by a genetic deficiency in liver glycogen phosphorylase, primarily presenting with an enlarged liver.
Tarui Disease (Type VII)
A glycogen storage disease resulting from a defect in muscle phosphofructokinase-1 (PFK-1) in muscle and erythrocytes, causing muscle cramps, exercise pain, and hemolytic anemia.
Mitochondrial Pyruvate Carrier (MPC)
An H+-coupled pyruvate-specific symporter located in the inner mitochondrial membrane that transports pyruvate from the cytosol into the mitochondrial matrix.
Pyruvate Dehydrogenase Complex (PDH Complex)
A multi-enzyme mitochondrial matrix complex consisting of three enzymes (E1, E2, E3) and five cofactors that catalyzes the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA, CO2, and NADH.
Thiamine Pyrophosphate (TPP)
A coenzyme derived from vitamin B1 utilized by pyruvate dehydrogenase (E1) whose thiazolium ring stabilizes carbanions to cleave bonds adjacent to a carbonyl group and transfer aldehydes.
Lipoate (Lipoic Acid)
An enzyme-bound cofactor covalently attached to a lysine residue of E2 containing two thiol groups that undergo reversible oxidation to a disulfide bond, transferring both electrons and acyl groups.
Coenzyme A (CoA-SH)
A cofactor derived from vitamin B5 (pantothenic acid) containing a reactive thiol (−SH) group that acts as an acyl group carrier by forming high-energy thioester bonds such as that in acetyl-CoA (ΔG∘′=−31.4kJ/mol).
Dihydrolipoyl Transacetylase (E2)
The central structural subunit of the PDH complex that uses a long lipoyllysine arm to swing substrates between active sites and transfer the acetyl group to CoA-SH.
Dihydrolipoyl Dehydrogenase (E3)
The third subunit of the PDH complex that reoxidizes the reduced dithiol form of lipoyllysine on E2 using an enzyme-bound FAD, followed by transferring hydride ions to NAD+ to generate NADH.
Substrate Channeling
The movement of chemical intermediates directly between adjacent active sites of a multi-enzyme complex without diffusion into the bulk solvent, minimizing side reactions and accelerating overall catalytic flux.
Citrate Synthase
An enzyme that catalyzes the irreversible aldol condensation of oxaloacetate and acetyl-CoA to form citrate, powered by the exergonic hydrolysis of the acetyl-CoA thioester bond.
Aconitase
An iron-sulfur containing enzyme that catalyzes the reversible two-step isomerization of citrate to isocitrate by first dehydrating citrate to cis-aconitate and then rehydrating it to position the hydroxyl group on C3.
Isocitrate Dehydrogenase
A mitochondrial matrix enzyme that catalyzes the irreversible oxidative decarboxylation of isocitrate to α-ketoglutarate, producing the cycle's first molecule of NADH and releasing CO2.
α-Ketoglutarate Dehydrogenase Complex
A multi-enzyme complex structurally and mechanistically homologous to the PDH complex that irreversibly decarboxylates α-ketoglutarate to succinyl-CoA, releasing the second CO2 and forming a second NADH.
Succinyl-CoA Synthetase
An enzyme that catalyzes the reversible cleavage of the high-energy thioester bond in succinyl-CoA to form succinate, coupled to the substrate-level phosphorylation of GDP or ADP to GTP or ATP.
Succinate Dehydrogenase
An enzyme of the citric acid cycle covalently linked to FAD that also functions as Complex II of the electron transport chain, catalyzing the reversible oxidation of succinate to fumarate.
Fumarase
An enzyme that stereospecifically catalyzes the reversible hydration of fumarate across its double bond to generate L-malate via a carbanion transition state.
L-Malate Dehydrogenase
A mitochondrial enzyme that catalyzes the reversible oxidation of L-malate to oxaloacetate, producing the third and final molecule of NADH in the citric acid cycle.
Amphibolic Pathway
A metabolic pathway that functions in both catabolism (oxidizing nutrients to generate energy) and anabolism (supplying precursor intermediates for biosynthesis).
Anaplerotic Reactions
Chemical reactions that replenish depleted catalytic intermediates of the citric acid cycle to ensure its continued functioning in oxidative and biosynthetic pathways.
Pyruvate Carboxylase
A biotin-dependent mitochondrial anaplerotic enzyme activated by acetyl-CoA that carboxylates pyruvate using ATP and HCO3− to form oxaloacetate.
Complex I (NADH:Ubiquinone Oxidoreductase)
A large multi-subunit complex in the inner mitochondrial membrane that transfers two electrons from NADH to ubiquinone (Q) while pumping four protons (4H+) from the matrix into the intermembrane space.
Complex II (Succinate Dehydrogenase)
An inner mitochondrial membrane complex that transfers electrons from succinate through FADH2 and iron-sulfur centers to ubiquinone without pumping any protons across the membrane.
Complex III (Ubiquinone:Cytochrome c Oxidoreductase)
An inner mitochondrial membrane respiratory complex that transfers electrons from reduced ubiquinol (QH2) to cytochrome c while pumping four protons (4H+) into the intermembrane space.
Complex IV (Cytochrome Oxidase)
The terminal respiratory complex that accepts four electrons from reduced cytochrome c molecules to reduce molecular oxygen (O2) to water (2H2O), pumping two protons (2H+) into the intermembrane space per electron pair.
Ubiquinone (Coenzyme Q)
A lipid-soluble, membrane-diffusible electron carrier in the inner mitochondrial membrane that carries one or two electrons and protons, coupling electron transfer between Complexes I, II, and III.
Cytochrome c
A water-soluble heme protein located in the mitochondrial intermembrane space that shuttles single electrons from Complex III to Complex IV.
Proton-Motive Force
The electrochemical potential across the inner mitochondrial membrane composed of a chemical pH gradient (ΔpH, alkaline inside) and an electrical potential (Δψ, negative inside) that powers ATP synthesis.

ATP Synthase (FoF1 Complex)
A multi-subunit enzyme complex consisting of a membrane-embedded proton pore (Fo) and a catalytic matrix peripheral unit (F1, composition α3β3γδϵ) that synthesizes ATP as protons pass down their concentration gradient.
Binding-Change Mechanism
The catalytic cycle of ATP synthase wherein each of the three β subunits cycles through three distinct conformations: β-Empty (very loose binding, ATP releases), β-ADP (loose binding of substrates), and β-ATP (tight catalytic synthesis of ATP).
Adenine Nucleotide Translocase
An inner mitochondrial membrane antiporter that exports ATP4− from the matrix into the intermembrane space in exchange for import of ADP3−, driven by the membrane's electrical potential.
Phosphate Translocase
An inner mitochondrial membrane symporter that brings inorganic phosphate (H2PO4−) into the matrix along with one proton (H+), utilizing the chemical proton gradient.
Antimycin A
A toxic respiratory inhibitor that blocks electron transfer from cytochrome b to cytochrome c1 in Complex III, thereby halting oxygen reduction and coupled ATP synthesis.

Glycerol 3-Phosphate Shuttle
An electron shuttle active in skeletal muscle and the brain that transfers reducing equivalents from cytosolic NADH to mitochondrial FAD, entering the respiratory chain at ubiquinone/Complex III and yielding 1.5ATP per NADH.

Malate-Aspartate Shuttle
An electron shuttle active in liver, kidney, and heart tissue that transfers cytosolic reducing equivalents from NADH to regenerate mitochondrial matrix NADH, entering at Complex I and yielding 2.5ATP per NADH.
P/O Ratio (Phosphate/Oxygen Ratio)
The stoichiometric ratio of moles of inorganic phosphate (Pi) consumed to synthesize ATP per mole of oxygen atoms reduced; equal to 2.5 for NADH (10protons/4protons) and 1.5 for FADH2 (6protons/4protons).
Substrate-Level Phosphorylation
The direct enzymatic formation of ATP or GTP by the transfer of a phosphate group from a phosphorylated metabolic intermediate, occurring independently of oxygen in glycolysis and the citric acid cycle.
Oxidative Phosphorylation
The synthesis of ATP from ADP and Pi driven by the flow of protons back across the inner mitochondrial membrane via ATP synthase, utilizing the electrochemical energy generated by electron transport to molecular oxygen.